Medicine and Dentistry
Inflammatory Bowel Disease
85%
Gut Microbiome
62%
Gut Microbiota
42%
Gut
35%
Microbiome
30%
Crohn's Disease
28%
Irritable Bowel Syndrome
22%
Patient with Inflammatory Bowel Disease
20%
Disease
19%
Anti-Inflammatory Drug
19%
Drug Therapy
17%
Inflammatory Disorder
14%
Metagenome
12%
Gastrointestinal Disease
12%
Population
9%
Tamsulosin
9%
Meta-Analysis
9%
Faecal Calprotectin
9%
Drug Repositioning
9%
Beta Defensin 2
9%
Dietary Pattern
9%
Patient Attitude
9%
Disease Exacerbation
9%
Antibiotics
9%
Gastrointestinal Tract
8%
Ulcerative Colitis
7%
Pleiotropy
7%
Small Intestine
6%
Lincosamide
6%
Proton-Pump Inhibitor
5%
Glycon
5%
Biological Marker
5%
Immunology and Microbiology
Gut Microbiome
100%
Inflammatory Bowel Disease
84%
Microbiome
55%
Crohn's Disease
23%
Intestine Flora
22%
Metabolome
19%
Metagenomics
16%
Comorbidity
14%
Metagenome
13%
Resistome
13%
Inflammatory Disorder
12%
Taxon
12%
Normal Human
11%
Metabolite
10%
Transplant Procedure
9%
Coronary Artery
9%
Pleiotropy
9%
Beta-Defensin 2
9%
Multi-Omics
9%
Solid Organ Transplantation
9%
Metabolism
8%
Antimicrobial Resistance
8%
Small Intestine
6%
Primary Sclerosing Cholangitis
6%
Virulence Factor
6%
Ulcerative Colitis
5%
Microbial Diversity
5%
Sample Size
5%
Population
5%
Gastrointestinal Tract
5%
Keyphrases
Inflammatory Bowel Disease
39%
Gut Microbiome
23%
Gut Microbiota
21%
Microbiome
17%
Gastrointestinal Diseases
13%
Microbiome Study
13%
Metagenomic Next-generation Sequencing (mNGS)
12%
Metabolic Function
11%
Chemical Compounds
9%
Multiple Substance Use
9%
Predictive Value
9%
Irritable Bowel Syndrome
9%
Population-based Cohort
9%
Polypharmacy
9%
Co-abundance Network
9%
Functional Change
9%
Positive Engagement
9%
Drug Efficacy
9%
Resistome
9%
Omics Data
9%
Laxatives
9%
Proton Pump Inhibitors
9%
Biological Therapy
9%
Meta-analysis
9%
Gut Metabolome
9%
Multiple Medications
9%
Gut Metagenome
9%
Human Gut Microbiota
9%
Antibiotics
9%
Comorbidity
9%
Clinical Application
9%
Gut Microbiota Composition
9%
Clinical Setting
9%
Metabolic Potential
9%
Drug Response
9%
Composition Function
9%
Composition Change
9%
Metformin
9%
Gut Bacteria
9%
Fecal Samples
9%
Disease Groups
9%
Co-abundance
8%
Multi-disease
6%
